MYND - MYnd Analytics, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
1.6462
-0.1038 (-5.93%)
As of 12:29PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close1.7500
Open1.7150
Bid1.6400 x 1000
Ask1.6500 x 1200
Day's Range1.6301 - 1.7150
52 Week Range1.1490 - 5.0490
Volume15,959
Avg. Volume160,585
Market Cap9.942M
Beta0.74
PE Ratio (TTM)N/A
EPS (TTM)-2.4920
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est5.83
Trade prices are not sourced from all markets
  • Is MYnd Analytics Inc (NASDAQ:MYND) A Financially Sound Company?
    Simply Wall St.23 days ago

    Is MYnd Analytics Inc (NASDAQ:MYND) A Financially Sound Company?

    Investors are always looking for growth in small-cap stocks like MYnd Analytics Inc (NASDAQ:MYND), with a market cap of US$12.38m. However, an important fact which most ignore is: how financiallyRead More...

  • Who Owns Most Of MYnd Analytics Inc (NASDAQ:MYND)?
    Simply Wall St.2 months ago

    Who Owns Most Of MYnd Analytics Inc (NASDAQ:MYND)?

    In this article, I will take a quick look at MYnd Analytics Inc’s (NASDAQ:MYND) recent ownership structure – an unconventional investing subject, but an important one. The impact of aRead More...

  • GlobeNewswire2 months ago

    MYnd Analytics Provides Business Update and Reports Significant Increase in Revenues for the Second Quarter of 2018

    MYnd Analytics, Inc. (MYND) (“MYnd” or the “Company”), a market leader in reducing costs and improving the delivery of mental health services through the combination of telemedicine and data analytics/artificial (augmented) intelligence, today provided a business update and reported financial results for the second quarter and six months ended March 31, 2018. The Company continues to integrate its recently acquired Arcadian Telepsychiatry business into its legacy business and is pleased to announce revenues of $459,900 for the second quarter and $581,900 for the six months ended March 31, 2018 compared with revenues of $31,900 for the second quarter ended March 31, 2017 and $54,100 for the six months ended March 31, 2017. “Telemedicine is one of the fastest growing areas of healthcare services today and directly addresses the shortage of mental health providers and the growing need for behavioral health services,” stated George Carpenter, CEO of MYnd.

  • Breakeven On The Horizon For MYnd Analytics Inc (NASDAQ:MYND)
    Simply Wall St.3 months ago

    Breakeven On The Horizon For MYnd Analytics Inc (NASDAQ:MYND)

    MYnd Analytics Inc’s (NASDAQ:MYND): MYnd Analytics, Inc. operates as a predictive analytics company primarily in the United States. The company’s loss has recently broadened since it announced a -US$7.11M lossRead More...

  • ACCESSWIRE3 months ago

    MYnd Analytics, Adding AI in Telemedicine, Analyst Report and Market Outlook

    NEW YORK, NY / ACCESSWIRE / April 17, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive ...

  • What does MYnd Analytics Inc’s (NASDAQ:MYND) Balance Sheet Tell Us About Its Future?
    Simply Wall St.3 months ago

    What does MYnd Analytics Inc’s (NASDAQ:MYND) Balance Sheet Tell Us About Its Future?

    Investors are always looking for growth in small-cap stocks like MYnd Analytics Inc (NASDAQ:MYND), with a market cap of US$5.50M. However, an important fact which most ignore is: how financiallyRead More...

  • MYnd Analytics Inc (NASDAQ:MYND): Should The Recent Earnings Drop Worry You?
    Simply Wall St.4 months ago

    MYnd Analytics Inc (NASDAQ:MYND): Should The Recent Earnings Drop Worry You?

    For long-term investors, assessing earnings trend over time and against industry benchmarks is more beneficial than examining a single earnings announcement at a point in time. Investors may find myRead More...

  • Is It Time To Buy MYnd Analytics Inc (NASDAQ:MYND)?
    Simply Wall St.6 months ago

    Is It Time To Buy MYnd Analytics Inc (NASDAQ:MYND)?

    MYnd Analytics Inc (NASDAQ:MYND), a healthcare services company based in United States, saw a double-digit share price rise of over 10% in the past couple of months on the NasdaqCM.Read More...

  • MYnd Analytics Inc (MYND): How Does It Impact Your Portfolio?
    Simply Wall St.8 months ago

    MYnd Analytics Inc (MYND): How Does It Impact Your Portfolio?

    If you are a shareholder in MYnd Analytics Inc’s (NASDAQ:MYND), or are thinking about investing in the company, knowing how it contributes to the risk and reward profile of yourRead More...

  • ACCESSWIRE10 months ago

    MYnd Analytics to Present at the MicroCap Conference on October 5th in New York City at the Essex House

    MISSION VIEJO, CA / ACCESSWIRE / September 28, 2017 / MYnd Analytics, Inc. (NASDAQ: MYND) , a predictive medicine company that brings objective physical findings to psychiatric treatment in order to reduce ...

  • MYnd Analytics, Inc. :MYND-US: Earnings Analysis: Q3, 2017 By the Numbers : August 24, 2017
    Capital Cube11 months ago

    MYnd Analytics, Inc. :MYND-US: Earnings Analysis: Q3, 2017 By the Numbers : August 24, 2017

    Categories: Yahoo FinanceGet free summary analysis MYnd Analytics, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of MYnd Analytics, Inc. – EnteroMedics Inc., Natus Medical Incorporated, MRI Interventions, Inc. and ResMed Inc. (ETRM-US, BABY-US, MRIC-US and RMD-US) that have also reported for this period. Highlights ... Read more (Read more...)